Therapeutic effectiveness of modern antiparkinson agents
Kurako, I.L.; Volianskiĭ, V.E.; Fadeev, S.M.
Vrachebnoe Delo 2: 7-11
1981
ISSN/ISBN: 0049-6804 PMID: 7222616 Document Number: 173729
Document emailed within 1 workday
Related Documents
Veje, V.O. 1981: Drug information: antiparkinson agents. I. Anticholinergic agents Sygeplejersken 81(34): 11Siegers, C.P. 1994: Adjuvant respiratory tract therapeutic agents. Therapeutic effectiveness Medizinische Monatsschrift für Pharmazeuten 17(10): 302-305
Staal-Schreinemachers, A.L.; Lakke, J.P. 1987: Antiparkinson agents Nederlands Tijdschrift Voor Geneeskunde 131(6): 228-230
Delwaide, P.J. 1996: L-dopa and antiparkinson agents Revue Medicale de Liege 51(1): 61-64
Veje, J.O. 1981: Drug information: antiparkinson agents Sygeplejersken 81(32): 10
Newman, S.P. 1984: Therapeutic inhalation agents and devices. Effectiveness in asthma and bronchitis Postgraduate Medicine 76(5): 194-203 206-7
Gjerden, P.; Slørdal, L. 1998: Clinical pharmacology of anticholinergic antiparkinson agents. a review with emphasis on acute toxicity Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(1): 53-55
Occelli, E.; Fontanella, L.; Testa, E. 1977: Bicyclic analogs of piperazine. XII. (1) - Synthesis of 3,8-diazabicyclo/3,2,1/octanes as potential antiparkinson agents Il Farmaco; Edizione Scientifica 32(4): 237-247
Tadori, Y.; Kobayashi, H. 2014: The therapeutic plasma concentrations of antiparkinson dopamine agonists and their in vitro pharmacology at dopamine receptors Nihon Shinkei Seishin Yakurigaku Zasshi 34(5-6): 127-132
Sigwald, J.; Raymondeaud, C.; Piot, C. 1973: Method for appraisal and measurement of extrapyramidal symptoms and signs. Clinical evaluation of Parkinsonism. Value in the evaluation of severeness, in the estimation of the evolutive potential, in the appreciation as strict as possible of the effectiveness of antiparkinson therapy La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 49(10): 693-704
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Pace, V.; Artico, M.; Ciccariello, M.; Bonanni, G. 1990: The current physiopathological, diagnostic, clinical and therapeutic considerations of peptic ulcer. a comparison between traditional and modern therapeutic methods Minerva Dietologica e Gastroenterologica 36(2): 63-75
Ohata, K.; Kohno, S. 1987: Progress of therapeutic agents for asthma--3) Trends in the development of leukotriene inhibitory agents Nihon Rinsho. Japanese Journal of Clinical Medicine 45(8): 1843-1852
Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Styła, Rł. 2014: Differences in effectiveness of intensive programs of treatment for neurotic and personality disorders. Is it worth to monitor the effectiveness of the therapeutic team? Psychiatria Polska 48(1): 157-171
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Van Zwieten, P.A. 1972: Modern antihypertensive agents Pharmaceutisch Weekblad 107(11): 185-191
Greeff, K. 1975: Pharmacology of modern antihypertensive agents Die Medizinische Welt 26(10): 413-416
Schlosser, V.; Spillner, G. 1981: Effectiveness of modern coronary surgery Fortschritte der Medizin 99(41): 1710-1713